[Pharmacogenetic/regulatory aspects seen from the viewpoint of the industry]. • Arctic Health

It appears no script is enabled within your browser. Please enable JavaScript to use this site.

Home

View Selections: 0 Items Help

[Pharmacogenetic/regulatory aspects seen from the viewpoint of the industry].

https://arctichealth.org/en/permalink/ahliterature174101

Source: Ugeskr Laeger. 2005 May 16;167(20):2160-4

Publication Type: Article

Date: May-16-2005

Author: Lars Hansen; Dorrit Andersen

Author Affiliation: Novo Nordisk A/S, Måløv. larh@novonordisk.Com

Source: Ugeskr Laeger. 2005 May 16;167(20):2160-4

Date: May-16-2005

Language: Danish

Publication Type: Article

Keywords: Clinical Trials as Topic; Denmark; Drug Industry - legislation & jurisprudence - trends; Drug and Narcotic Control - legislation & jurisprudence; Europe; Guidelines as Topic; Humans; Pharmacogenetics - legislation & jurisprudence - trends; Technology, Pharmaceutical - legislation & jurisprudence - trends

PubMed ID: 15987073 View in PubMed